Managing multiple sclerosis (MS) through pre-conception, pregnancy and post-partum periods can be challenging, as there is limited data in this patient population. This program reviews the impact of pregnancy on MS activity, choices of DMT during pregnancy, and recommendations postpartum. The overall goal is to increase clinicians’ confidence in managing patients before, during, and after pregnancy.
This program has received an unrestricted educational grant or in-kind support from Roche.